Search

everythinglearnresearchcommunity

for

Search:↓

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Immune cells affect hair growth and could lead to new hair loss treatments.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

Psoriasis is a common, genetically influenced skin disease worsened by stress and lifestyle, but targeted treatments are promising.

COVID-19 vaccination is generally safe for people with Hidradenitis Suppurativa.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Baricitinib is the most effective treatment for alopecia areata.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Managing multiple autoimmune diseases in one patient is very challenging.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

Certain factors like being female, having high cholesterol, using Medicaid, and previous non-biologic treatments increase the risk of multiple biologic failures in psoriasis patients.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

New treatments for alopecia areata show promise, but no cure exists and responses to treatments vary.

New treatments for atopic dermatitis and alopecia areata have been developed using a targeted approach.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

New treatments for hair loss focus on targeting specific causes to improve effectiveness and safety.

New treatments for hair loss show promise with advanced therapies and better targeting.